Repeat expansion disease: progress and puzzles in disease pathogenesis

Repeat expansion mutations cause at least 22 inherited neurological diseases. The complexity of repeat disease genetics and pathobiology has revealed unexpected shared themes and mechanistic pathways among the diseases, such as RNA toxicity. Also, investigation of the polyglutamine diseases has identified post-translational modification as a key step in the pathogenic cascade and has shown that the autophagy pathway has an important role in the degradation of misfolded proteins — two themes that are likely to be relevant to the entire neurodegeneration field. Insights from repeat disease research are catalysing new lines of study that should not only elucidate molecular mechanisms of disease but also highlight opportunities for therapeutic intervention for these currently untreatable disorders.

[1]  Janghoo Lim,et al.  Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1 , 2008, Nature.

[2]  J. Sutcliffe,et al.  Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome , 1991, Cell.

[3]  C. Amemiya,et al.  Cloning of the essential myotonic dystrophy region and mapping of the putative defect , 1992, Nature.

[4]  S. Tapscott,et al.  An antisense transcript spanning the CGG repeat region of FMR1 is upregulated in premutation carriers but silenced in full mutation individuals. , 2007, Human molecular genetics.

[5]  Chi Li,et al.  Growth Factor Regulation of Autophagy and Cell Survival in the Absence of Apoptosis , 2005, Cell.

[6]  Fabrice P Cordelières,et al.  The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt. , 2002, Developmental cell.

[7]  Abhishek Aphale,et al.  Androgen Receptor Acetylation Site Mutations Cause Trafficking Defects, Misfolding, and Aggregation Similar to Expanded Glutamine Tracts* , 2004, Journal of Biological Chemistry.

[8]  J. Taylor,et al.  The Role of Autophagy in Age-Related Neurodegeneration , 2007, Neurosignals.

[9]  S. Finkbeiner,et al.  Serines 13 and 16 Are Critical Determinants of Full-Length Human Mutant Huntingtin Induced Disease Pathogenesis in HD Mice , 2009, Neuron.

[10]  L. Thompson,et al.  Autophagy regulates the processing of amino terminal huntingtin fragments. , 2003, Human molecular genetics.

[11]  M. MacDonald,et al.  Huntingtin facilitates polycomb repressive complex 2 , 2009, Human molecular genetics.

[12]  D. Sulzer,et al.  Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration. , 2001, Human molecular genetics.

[13]  S. Humbert,et al.  Huntingtin phosphorylation acts as a molecular switch for anterograde/retrograde transport in neurons , 2008, The EMBO journal.

[14]  Rainer Duden,et al.  Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. , 2002, Human molecular genetics.

[15]  S. Finkbeiner,et al.  Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy. , 2009, Human molecular genetics.

[16]  D. Rubinsztein,et al.  Trehalose, a Novel mTOR-independent Autophagy Enhancer, Accelerates the Clearance of Mutant Huntingtin and α-Synuclein* , 2007, Journal of Biological Chemistry.

[17]  D. Rubinsztein,et al.  Trehalose reduces aggregate formation and delays pathology in a transgenic mouse model of oculopharyngeal muscular dystrophy. , 2006, Human molecular genetics.

[18]  Mariette Schrier,et al.  The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor/ataxia syndrome. , 2003, Human molecular genetics.

[19]  Francesco Scaravilli,et al.  Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease , 2004, Nature Genetics.

[20]  Peng Jin,et al.  RNA-Mediated Neurodegeneration Caused by the Fragile X Premutation rCGG Repeats in Drosophila , 2003, Neuron.

[21]  A. Berns,et al.  Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice , 1996, Nature Genetics.

[22]  N. Nukina,et al.  Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease , 2004, Nature Medicine.

[23]  Lu Gan,et al.  Huntingtin phosphorylation on serine 421 is significantly reduced in the striatum and by polyglutamine expansion in vivo. , 2005, Human molecular genetics.

[24]  J. Taylor,et al.  Autophagy and the ubiquitin-proteasome system: collaborators in neuroprotection. , 2008, Biochimica et biophysica acta.

[25]  R. J. White,et al.  Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. , 2000, Science.

[26]  A. Cuervo,et al.  Oxidative stress and autophagy. , 2006, Antioxidants & redox signaling.

[27]  K. Kinzler,et al.  The Antisense Transcriptomes of Human Cells , 2008, Science.

[28]  E. Seto,et al.  Acetylation and deacetylation of non-histone proteins. , 2005, Gene.

[29]  K. Fischbeck,et al.  Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy , 1991, Nature.

[30]  A. Feinberg,et al.  CTCFL/BORIS is a methylation-independent DNA-binding protein that preferentially binds to the paternal H19 differentially methylated region. , 2008, Cancer research.

[31]  Fabrice P Cordelières,et al.  Huntingtin Controls Neurotrophic Support and Survival of Neurons by Enhancing BDNF Vesicular Transport along Microtubules , 2004, Cell.

[32]  R. Moxley,et al.  Proximal myotonic myopathy. , 1995, Muscle & nerve.

[33]  W. Brown,et al.  Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. , 2003, American journal of human genetics.

[34]  I. Kiss,et al.  muscleblind, a gene required for photoreceptor differentiation in Drosophila, encodes novel nuclear Cys3His-type zinc-finger-containing proteins. , 1997, Development.

[35]  B. Byrne,et al.  Recruitment of human muscleblind proteins to (CUG)n expansions associated with myotonic dystrophy , 2000, The EMBO journal.

[36]  S. Tapscott,et al.  CTCF-binding sites flank CTG/CAG repeats and form a methylation-sensitive insulator at the DM1 locus , 2001, Nature Genetics.

[37]  H. Kamaya,et al.  Dissociation constants of local anesthetics and their temperature dependence. , 1983, Anesthesia and analgesia.

[38]  P. Hollenbeck.  Products of endocytosis and autophagy are retrieved from axons by regulated retrograde organelle transport , 1993, The Journal of cell biology.

[39]  Hideyuki Okano,et al.  Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice , 2006, Nature.

[40]  M. Mutsuddi,et al.  The Spinocerebellar Ataxia 8 Noncoding RNA Causes Neurodegeneration and Associates with Staufen in Drosophila , 2004, Current Biology.

[41]  T. Bird,et al.  An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8) , 1999, Nature Genetics.

[42]  N. Déglon,et al.  Inhibition of Calcineurin by FK506 Protects against Polyglutamine-Huntingtin Toxicity through an Increase of Huntingtin Phosphorylation at S421 , 2006, The Journal of Neuroscience.

[43]  T. Ebner,et al.  RNA Gain-of-Function in Spinocerebellar Ataxia Type 8 , 2009, PLoS genetics.

[44]  N. Heintz,et al.  A Novel Protein Complex Linking the δ2 Glutamate Receptor and Autophagy Implications for Neurodegeneration in Lurcher Mice , 2002, Neuron.

[45]  L. Schut,et al.  Spinocerebellar Ataxia Type 8 , 2006 .

[46]  K. Fischbeck,et al.  Akt blocks ligand binding and protects against expanded polyglutamine androgen receptor toxicity. , 2007, Human molecular genetics.

[47]  Alexei Degterev,et al.  Diversity in the Mechanisms of Neuronal Cell Death , 2003, Neuron.

[48]  C. Thompson,et al.  Autophagy: basic principles and relevance to disease. , 2008, Annual review of pathology.

[49]  S. Finkbeiner,et al.  IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome , 2009, The Journal of cell biology.

[50]  Moon-Kyoung Bae,et al.  Regulation and Destabilization of HIF-1α by ARD1-Mediated Acetylation , 2002, Cell.

[51]  S. Tapscott,et al.  Antisense transcription and heterochromatin at the DM1 CTG repeats are constrained by CTCF. , 2005, Molecular cell.

[52]  K. Xia,et al.  Research on screening and identification of proteins interacting with ataxin-3. , 2005, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics.

[53]  M. Hayden,et al.  Phosphorylation of huntingtin reduces the accumulation of its nuclear fragments , 2009, Molecular and Cellular Neuroscience.

[54]  A. Hackam,et al.  Kennedy's Disease , 1999, Journal of neurochemistry.

[55]  M. Iino,et al.  Junctophilins: a novel family of junctional membrane complex proteins. , 2000, Molecular cell.

[56]  V. Willour,et al.  A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion , 2001, Annals of neurology.

[57]  T. Ebner,et al.  Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8 , 2006, Nature Genetics.

[58]  Gene W. Yeo,et al.  Divergent Transcription from Active Promoters , 2008, Science.

[59]  Masaaki Komatsu,et al.  Essential role for autophagy protein Atg7 in the maintenance of axonal homeostasis and the prevention of axonal degeneration , 2007, Proceedings of the National Academy of Sciences.

[60]  I. Kanazawa,et al.  HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain , 1997, Nature Genetics.

[61]  Tyson A. Clark,et al.  Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy , 2010, Nature Structural &Molecular Biology.

[62]  H. Zoghbi,et al.  Interaction of Akt-Phosphorylated Ataxin-1 with 14-3-3 Mediates Neurodegeneration in Spinocerebellar Ataxia Type 1 , 2003, Cell.

[63]  M. DiFiglia,et al.  Huntingtin Expression Stimulates Endosomal–Lysosomal Activity, Endosome Tubulation, and Autophagy , 2000, The Journal of Neuroscience.

[64]  D. Le Paslier,et al.  Isolation of sequences that span the fragile X and identification of a fragile X-related CpG island. , 1991, Science.

[65]  S. Snyder,et al.  A huntingtin-associated protein enriched in brain with implications for pathology , 1995, Nature.

[66]  Tao Zhang,et al.  Phosphorylation of ataxin-3 by glycogen synthase kinase 3beta at serine 256 regulates the aggregation of ataxin-3. , 2007, Biochemical and biophysical research communications.

[67]  Michael Q. Zhang,et al.  Analysis of the Vertebrate Insulator Protein CTCF-Binding Sites in the Human Genome , 2007, Cell.

[68]  L. Ellerby,et al.  Posttranslational Modification of Ataxin-7 at Lysine 257 Prevents Autophagy-Mediated Turnover of an N-Terminal Caspase-7 Cleavage Fragment , 2009, The Journal of Neuroscience.

[69]  L. Ellerby,et al.  Kennedy's Disease , 2003, Journal of Biological Chemistry.

[70]  N. Bonini,et al.  RNA toxicity is a component of ataxin-3 degeneration in Drosophila , 2008, Nature.

[71]  E. Eichler,et al.  Human and murine FMR-1: alternative splicing and translational initiation downstream of the CGG–repeat , 1993, Nature Genetics.

[72]  R. Carraway,et al.  Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons , 1995, Neuron.

[73]  S. Hersch,et al.  Interaction of Huntingtin-Associated Protein with Dynactin P150Glued , 1998, The Journal of Neuroscience.

[74]  Michael P. Cusack,et al.  Huntingtin Phosphorylation Sites Mapped by Mass Spectrometry , 2006, Journal of Biological Chemistry.

[75]  Harry T Orr,et al.  Ataxin-1 Nuclear Localization and Aggregation Role in Polyglutamine-Induced Disease in SCA1 Transgenic Mice , 1998, Cell.

[76]  R. Moxley,et al.  Proximal myotonic myopathy. Clinical features of a multisystem disorder similar to myotonic dystrophy. , 1995, Archives of neurology.

[77]  C. Moncrieff,et al.  Myotonic dystrophy: will the real gene please step forward! , 1996, Human molecular genetics.

[78]  K. Davies,et al.  Physical mapping across the fragile X: Hypermethylation and clinical expression of the fragile X syndrome , 1991, Cell.

[79]  Jeannie T. Lee,et al.  CTCF, a Candidate Trans-Acting Factor for X-Inactivation Choice , 2001, Science.

[80]  Leighton J. Core,et al.  Nascent RNA Sequencing Reveals Widespread Pausing and Divergent Initiation at Human Promoters , 2008, Science.

[81]  J. Gorski,et al.  Early Striatal Dendrite Deficits followed by Neuron Loss with Advanced Age in the Absence of Anterograde Cortical Brain-Derived Neurotrophic Factor , 2004, The Journal of Neuroscience.

[82]  J. Conner,et al.  Anterograde transport of brain-derived neurotrophic factor and its role in the brain , 1997, Nature.

[83]  Fumiaki Tanaka,et al.  Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein. , 2003, Human molecular genetics.

[84]  D. Rubinsztein,et al.  A rational mechanism for combination treatment of Huntington's disease using lithium and rapamycin. , 2008, Human molecular genetics.

[85]  S. Subramony,et al.  Bergmann Glial S100B Activates Myo-inositol Monophosphatase 1 and Co-localizes to Purkinje Cell Vacuoles in SCA1 Transgenic Mice , 2009, The Cerebellum.

[86]  R. Richards,et al.  The pathogenic agent in Drosophila models of 'polyglutamine' diseases. , 2005, Human molecular genetics.

[87]  J. Iñiguez-Lluhí,et al.  Small Ubiquitin-like Modifier (SUMO) Modification of the Androgen Receptor Attenuates Polyglutamine-mediated Aggregation*♦ , 2009, The Journal of Biological Chemistry.

[88]  B. Wieringa,et al.  Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy , 2009, Proceedings of the National Academy of Sciences.

[89]  Jeffrey N. Savas,et al.  Acetylation Targets Mutant Huntingtin to Autophagosomes for Degradation , 2009, Cell.

[90]  Masaaki Komatsu,et al.  Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice , 2005, The Journal of cell biology.

[91]  Dustin E. Schones,et al.  High-Resolution Profiling of Histone Methylations in the Human Genome , 2007, Cell.

[92]  C. Ross,et al.  Huntington's disease–like 2 is associated with CUG repeat‐containing RNA foci , 2007, Annals of neurology.

[93]  S. Naylor,et al.  Myotonic Dystrophy Type 2 Caused by a CCTG Expansion in Intron 1 of ZNF9 , 2001, Science.

[94]  N. Aronin,et al.  Disruption of Rab11 activity in a knock-in mouse model of Huntington's disease , 2009, Neurobiology of Disease.

[95]  C. Duyckaerts,et al.  Similarities between spinocerebellar ataxia type 7 (SCA7) cell models and human brain: proteins recruited in inclusions and activation of caspase-3. , 2001, Human molecular genetics.

[96]  J. Cha,et al.  Altered Histone Monoubiquitylation Mediated by Mutant Huntingtin Induces Transcriptional Dysregulation , 2008, The Journal of Neuroscience.

[97]  David E. Housman,et al.  Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy , 1992, Nature.

[98]  P. Jin,et al.  Pur α Binds to rCGG Repeats and Modulates Repeat-Mediated Neurodegeneration in a Drosophila Model of Fragile X Tremor/Ataxia Syndrome , 2007, Neuron.

[99]  Mikkel H. Schierup,et al.  RNA Exosome Depletion Reveals Transcription Upstream of Active Human Promoters , 2008, Science.

[100]  P. Pandolfi,et al.  SUMO Modification of Huntingtin and Huntington's Disease Pathology , 2004, Science.

[101]  R. Atwal,et al.  Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity. , 2007, Human molecular genetics.

[102]  L. Ranum,et al.  Genetic mapping of a second myotonic dystrophy locus , 1998, Nature Genetics.

[103]  S. Humbert,et al.  Phosphorylation of mutant huntingtin at S421 restores anterograde and retrograde transport in neurons. , 2008, Human molecular genetics.

[104]  Krzysztof Sobczak,et al.  Reversal of RNA Dominance by Displacement of Protein Sequestered on Triplet Repeat RNA , 2009, Science.

[105]  E. Nagata,et al.  Autophagosome-like vacuole formation in Huntington's disease lymphoblasts , 2004, Neuroreport.

[106]  J. Penney,et al.  Huntingtin localization in brains of normal and Huntington's disease patients , 1997, Annals of neurology.

[107]  P. Worley,et al.  Huntingtin-associated protein 1 (HAP1) interacts with the p150Glued subunit of dynactin. , 1997, Human molecular genetics.

[108]  C. E. Pearson,et al.  Repeat instability: mechanisms of dynamic mutations , 2005, Nature Reviews Genetics.

[109]  Effat S. Emamian,et al.  Serine 776 of Ataxin-1 Is Critical for Polyglutamine-Induced Disease in SCA1 Transgenic Mice , 2003, Neuron.

[110]  David E. Housman,et al.  Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member , 1992, Cell.

[111]  A Prokop,et al.  The muscleblind gene participates in the organization of Z-bands and epidermal attachments of Drosophila muscles and is regulated by Dmef2. , 1998, Developmental biology.

[112]  R. Nixon,et al.  Neurodegenerative lysosomal disorders: A continuum from development to late age , 2008, Autophagy.

[113]  John I. Clark,et al.  Mice deficient in Six5 develop cataracts: implications for myotonic dystrophy , 2000, Nature Genetics.

[114]  D. Rubinsztein,et al.  Rapamycin alleviates toxicity of different aggregate-prone proteins. , 2006, Human molecular genetics.

[115]  D. Munoz.  Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. , 2002, Neurology.

[116]  Stephen J. Tapscott,et al.  CTCF cis-Regulates Trinucleotide Repeat Instability in an Epigenetic Manner: A Novel Basis for Mutational Hot Spot Determination , 2008, PLoS genetics.

[117]  Dan Garza,et al.  HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS , 2007, Nature.

[118]  Paul M. Rindler,et al.  Epigenetic Silencing in Friedreich Ataxia Is Associated with Depletion of CTCF (CCCTC-Binding Factor) and Antisense Transcription , 2009, PloS one.

[119]  K. Wada,et al.  [The ubiquitin-proteasome system and neurodegeneration]. , 2001, Rinsho shinkeigaku = Clinical neurology.

[120]  A. Spada,et al.  Polyglutamines Placed into Context , 2003, Neuron.

[121]  M. D. Del Bigio,et al.  Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. , 2002, Brain : a journal of neurology.

[122]  W. Hauswirth,et al.  A Muscleblind Knockout Model for Myotonic Dystrophy , 2003, Science.

[123]  T. Cooper,et al.  Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. , 1998, Science.

[124]  L. Johnson,et al.  Structural basis for control by phosphorylation. , 1997, Chemical reviews.

[125]  P. Jin,et al.  RNA-Binding Proteins hnRNP A2/B1 and CUGBP1 Suppress Fragile X CGG Premutation Repeat-Induced Neurodegeneration in a Drosophila Model of FXTAS , 2007, Neuron.

[126]  J. Taylor,et al.  HDAC6 at the Intersection of Autophagy, the Ubiquitin-proteasome System, and Neurodegeneration , 2007, Autophagy.

[127]  M. MacDonald,et al.  The serum‐ and glucocorticoid‐induced kinase SGK inhibits mutant huntingtin‐induced toxicity by phosphorylating serine 421 of huntingtin , 2004, The European journal of neuroscience.

[128]  Masaaki Komatsu,et al.  Loss of autophagy in the central nervous system causes neurodegeneration in mice , 2006, Nature.

[129]  R. Gellibolian,et al.  Long CCG triplet repeat blocks exclude nucleosomes: a possible mechanism for the nature of fragile sites in chromosomes. , 1996, Journal of molecular biology.

[130]  R Ohlsson,et al.  CTCF is a uniquely versatile transcription regulator linked to epigenetics and disease. , 2001, Trends in genetics : TIG.

[131]  G. Sobue,et al.  Testosterone Reduction Prevents Phenotypic Expression in a Transgenic Mouse Model of Spinal and Bulbar Muscular Atrophy , 2002, Neuron.

[132]  S. Snyder,et al.  Rhes, a Striatal Specific Protein, Mediates Mutant-Huntingtin Cytotoxicity , 2009, Science.

[133]  Kevin Fogarty,et al.  Mutant Huntingtin Impairs Vesicle Formation from Recycling Endosomes by Interfering with Rab11 Activity , 2009, Molecular and Cellular Biology.

[134]  M. Hahne,et al.  Cell Death , 2010, Cell Death and Differentiation.

[135]  H. Yasuda,et al.  SUMO-1 co-localized with mutant atrophin-1 with expanded polyglutamines accelerates intranuclear aggregation and cell death , 2002, Neuroreport.

[136]  M. Kano,et al.  Motor discoordination in mutant mice lacking junctophilin type 3. , 2002, Biochemical and biophysical research communications.

[137]  L. Timchenko,et al.  Myotonic dystrophy: the role of RNA CUG triplet repeats. , 1999, American journal of human genetics.